SHARPE
Reported results
- Q3 2026 Net Sales were $2.8 billion, up approximately 1% as reported and approximately flat on an adjusted basis.
- Q3 2026 Net Earnings were $163 million, or 5.9% of Net Sales.
- Q3 2026 Diluted EPS was $2.72, while adjusted EPS was $2.72.
- Q3 2026 Operating income was $188 million, and adjusted operating income was $200 million.
- Q3 2026 adjusted EBITDA was approximately $353 million, with an adjusted EBITDA margin of 12.7%.
- Q3 2026 Net Cash Provided by Operating Activities was $471 million, and Free Cash Flow was $390 million.
Guidance
- For Q4 2026, the Company expects adjusted EPS in the range of $1.35 to $1.45.
- The Company anticipates full-year capital expenditures of approximately $445 million.
- For Q4 2026 guidance assumptions, the Company expects Adjusted Net Interest Expense of approximately $4 to $5 million.
- For Q4 2026 guidance assumptions, the Company expects Adjusted Depreciation & Amortization Expense of approximately $148 million.
- For Q4 2026 guidance assumptions, the Company expects an Adjusted Tax Rate of approximately 23.5%.
- For Q4 2026 guidance assumptions, the Company expects a Weighted Average Diluted Share Count of approximately 58.5 million.
Price and volatility reaction
The stock moved +7.2% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -10.2 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 129.99 | 2026-10-29 |
| Close after release | 139.41 | 2026-10-30 |
| Realised move | +7.2% | close to close |
| 30d ATM IV change | -10.2 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-29 (8-K, Item 2.02). Read the original filing on sec.gov.